News

Back

BIOCERA-VET: a promising alternative to autologous bone graft in canine arthrodesis

April 27th 2021

BSCB Dev S.A

TheraVet S.A., a pioneering company in the management of osteoarticular diseases in pets, announces today the positive efficacy results of BIOCERA-VET, its new generation bone substitute for the treatment of bone surgeries in small companions, in bone fusion in canine arthrodesis. Please discover the press release here.